60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$0.85 -0.04 (-4.47%)
As of: Oct 22, 2026 · 3:25 PM EDT

60 Degrees Pharmaceuticals (SXTP) Invested Capital (2022 - 2025)

Updated

60 Degrees Pharmaceuticals' Invested Capital came in at $3.62 million for Q4 2025, down 12.0% from $4.11 million a year earlier.

Analysis

60 Degrees Pharmaceuticals (SXTP) Invested Capital (2022 - 2025) Analysis & Trends

Going back to Q4 2022, 60 Degrees Pharmaceuticals' Invested Capital data covers 6 quarters.

  • Going back by year, Invested Capital was $4.11 million in FY2024 (-14.6%), $4.81 million in FY2023 and -$1.91 million in FY2022.
  • The Q4 2025 figure represents the lowest quarterly Invested Capital since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 126.18 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 64.89 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 82.72 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 38.08 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 148.69 Bn
10 60 Degrees Pharmaceuticals 2.26 Mn 1.23 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.62 Mn
Dec 31, 2024 4.11 Mn
Mar 31, 2024 7.13 Mn
Dec 31, 2023 4.82 Mn
Sep 30, 2023 8.69 Mn
Jun 30, 2023 27.14 Mn
Dec 31, 2022 -1.91 Mn
API Access

60 Degrees Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=SXTP&period=max&api_key=YOUR_API_KEY